Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc | 5,061,175 | 5,061,175 | 0 | $620.40M | $713.07M | 7.19% | +$92.67M |
| argenx SEADR(ARGX) | 709,446 | 711,584 | +2,138 | $658.20M | $682.35M | 6.88% | +$24.14M |
| CG Oncology, Inc.(CGON) | 8,514,590 | 8,514,590 | 0 | $604.96M | $603.60M | 6.08% | -$1.36M |
| iRhythm Holdings, Inc.(IRTC) | 2,182,631 | 3,118,913 | +936,282 | $259.62M | $354.50M | 3.57% | +$94.87M |
| Insmed Incorporated(INSM) | 4,842,880 | 3,096,545 | -1,746,335 | $516.35M | $353.44M | 3.56% | -$162.91M |
| Tango Therapeutics, Inc.(TNGX) | 13,900,620 | 14,048,477 | +147,857 | $434.53M | $350.51M | 3.53% | -$84.02M |
| Erasca, Inc.(ERAS) | 17,946,754 | 22,446,754 | +4,500,000 | $328.78M | $329.07M | 3.32% | +$284.9K |
| Spyre Therapeutics, Inc.(SYRE) | 4,251,996 | 3,691,791 | -560,205 | $377.49M | $328.68M | 3.31% | -$48.81M |
| RadNet, Inc.(RDNT) | 4,846,958 | 4,630,697 | -216,261 | $298.91M | $319.24M | 3.22% | +$20.33M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 3,357,059 | 3,484,066 | +127,007 | $211.29M | $273.88M | 2.76% | +$62.59M |
| Zai Lab LimitedADR(ZLAB) | 6,574,032 | 10,350,973 | +3,776,941 | $124.91M | $272.64M | 2.75% | +$147.74M |
| Repligen Corporation(RGEN) | 1,240,637 | 1,385,398 | +144,761 | $169.27M | $266.32M | 2.68% | +$97.04M |
| Guardant Health, Inc.(GH) | 1,481,033 | 1,481,033 | 0 | $222.20M | $264.16M | 2.66% | +$41.96M |
| Celcuity Inc.(CELC) | 3,304,903 | 3,304,903 | 0 | $345.76M | $262.81M | 2.65% | -$82.95M |
| Oruka Therapeutics, Inc.(ORKA) | 3,139,030 | 3,139,030 | 0 | $298.74M | $261.45M | 2.64% | -$37.29M |
| Natera, Inc.(NTRA) | 1,000,000 | 600,000 | -400,000 | $271.45M | $247.99M | 2.50% | -$23.46M |
| Cytokinetics, Incorporated(CYTK) | 2,862,003 | 2,862,003 | 0 | $243.81M | $188.63M | 1.90% | -$55.18M |
| UroGen Pharma Ltd.(URGN) | 4,543,895 | 4,543,895 | 0 | $167.22M | $184.62M | 1.86% | +$17.40M |
| Establishment Labs Holdings Inc.(ESTA) | 2,655,695 | 2,665,695 | +10,000 | $227.89M | $171.06M | 1.72% | -$56.83M |
| Xencor, Inc.(XNCR) | 6,777,461 | 6,827,461 | +50,000 | $109.12M | $170.35M | 1.72% | +$61.23M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,993,687 | 312,817 | -1,680,870 | $1.07B | $157.65M | 1.59% | -$912.86M |
| Immunocore Holdings plcADS(IMCR) | 4,869,798 | 4,869,798 | 0 | $154.62M | $147.51M | 1.49% | -$7.11M |
| Stoke Therapeutics, Inc.(STOK) | 5,623,525 | 5,623,525 | 0 | $184.00M | $146.21M | 1.47% | -$37.79M |
| Acadia Pharmaceuticals Inc | 7,144,524 | 7,144,524 | 0 | $180.76M | $143.96M | 1.45% | -$36.79M |
| Kodiak Sciences Inc.(KOD) | 1,487,934 | 1,487,934 | 0 | $57.97M | $141.06M | 1.42% | +$83.09M |
| GH Research PLC(GHRS) | 5,933,815 | 5,933,815 | 0 | $159.50M | $139.33M | 1.40% | -$20.17M |
| COMPASS Pathways plcADS(CMPS) | 10,700,974 | 10,948,591 | +247,617 | $151.42M | $136.20M | 1.37% | -$15.22M |
| Neurocrine Biosciences, Inc.(NBIX) | 1,267,925 | 942,684 | -325,241 | $213.69M | $133.71M | 1.35% | -$79.98M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 7,796,895 | 8,529,394 | +732,499 | $260.34M | $128.20M | 1.29% | -$132.14M |
| Kailera Therapeutics Inc | 10,776,820 | 10,776,820 | 0 | $237.41M | $123.07M | 1.24% | -$114.34M |
| Belite Bio, IncADS(BLTE) | 715,332 | 715,332 | 0 | $110.15M | $121.48M | 1.22% | +$11.33M |
| Immatics N.V.SHS(IMTX) | 12,946,176 | 13,521,551 | +575,375 | $131.14M | $118.72M | 1.20% | -$12.43M |
| Replimune Group, Inc.(REPL) | 7,411,581 | 8,491,525 | +1,079,944 | $82.05M | $112.43M | 1.13% | +$30.38M |
| Immunovant, Inc.(IMVT) | 3,177,849 | 3,177,849 | 0 | $122.44M | $107.35M | 1.08% | -$15.09M |
| PTC Therapeutics, Inc.(PTCT) | 7,746,415 | 1,615,819 | -6,130,596 | $631.88M | $104.67M | 1.06% | -$527.20M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 4,910,126 | +4,910,126 | $0 | $101.10M | 1.02% | +$101.10M |
| Castle Biosciences, Inc.(CSTL) | 2,778,335 | 2,778,335 | 0 | $66.26M | $98.71M | 0.99% | +$32.45M |
| uniQure N.V.SHS(QURE) | 3,941,572 | 3,941,572 | 0 | $181.55M | $95.23M | 0.96% | -$86.32M |
| Cogent Biosciences, Inc.(COGT) | 2,309,021 | 2,309,021 | 0 | $89.36M | $73.93M | 0.75% | -$15.42M |
| Structure Therapeutics IncADS | 1,607,507 | 2,282,138 | +674,631 | $86.27M | $71.36M | 0.72% | -$14.91M |
| Axogen, Inc.(AXGN) | 1,011,576 | 1,659,376 | +647,800 | $46.72M | $69.56M | 0.70% | +$22.84M |
| Taysha Gene Therapies, Inc.(TSHA) | 13,560,258 | 13,560,258 | 0 | $92.35M | $66.04M | 0.67% | -$26.31M |
| Orchestra Biomed Hldgs Inc | 9,556,063 | 9,556,063 | 0 | $41.23M | $59.44M | 0.60% | +$18.20M |
| Verastem, Inc.(VSTM) | 6,635,793 | 6,718,081 | +82,288 | $25.35M | $54.08M | 0.55% | +$28.73M |
| Danaher Corporation(DHR) | 230,000 | 230,000 | 0 | $43.81M | $50.96M | 0.51% | +$7.15M |
| Hinge Health, Inc.CL A(HNGE) | 500,000 | 500,000 | 0 | $41.50M | $48.62M | 0.49% | +$7.12M |
| Rocket Pharmaceuticals Inc | 17,687,772 | 17,687,772 | 0 | $60.49M | $46.52M | 0.47% | -$13.97M |
| Solid Biosciences Inc | 3,892,926 | 5,905,426 | +2,012,500 | $38.89M | $42.70M | 0.43% | +$3.81M |
| Neurogene Inc | 1,362,456 | 1,512,456 | +150,000 | $42.85M | $42.08M | 0.42% | -$772.7K |
| Cullinan Therapeutics Inc | 2,364,347 | 2,364,347 | 0 | $43.05M | $36.29M | 0.37% | -$6.76M |
| Aquestive Therapeutics Inc | 7,426,471 | 7,426,471 | 0 | $30.89M | $34.38M | 0.35% | +$3.49M |
| Candel Therapeutics Inc | 6,422,018 | 3,211,008 | -3,211,010 | $66.15M | $33.52M | 0.34% | -$32.62M |
| Aktis Oncology, Inc.(AKTS) | 1,592,043 | 1,592,043 | 0 | $51.31M | $31.00M | 0.31% | -$20.31M |
| Savara Inc.(SVRA) | 5,952,380 | 5,952,380 | 0 | $36.67M | $30.71M | 0.31% | -$5.95M |
| Korsana Biosciences Inc | 0 | 877,020 | +877,020 | $0 | $28.06M | 0.28% | +$28.06M |
| Kymera Therapeutics, Inc.(KYMR) | 240,000 | 240,000 | 0 | $27.52M | $26.83M | 0.27% | -$691.2K |
| Dianthus Therapeutics, Inc.(DNTH) | 248,063 | 248,063 | 0 | $24.18M | $21.84M | 0.22% | -$2.34M |
| Beta Bionics, Inc.(BBNX) | 1,500,000 | 998,855 | -501,145 | $23.50M | $18.96M | 0.19% | -$4.55M |
| Larimar Therapeutics Inc | 2,565,999 | 5,820,891 | +3,254,892 | $7.83M | $18.60M | 0.19% | +$10.77M |
| Pyxis Oncology Inc | 0 | 6,506,229 | +6,506,229 | $0 | $15.16M | 0.15% | +$15.16M |
| Century Therapeutics Inc | 8,695,652 | 8,695,652 | 0 | $21.30M | $14.87M | 0.15% | -$6.43M |
| Beam Therapeutics Inc.(BEAM) | 570,394 | 570,394 | 0 | $19.58M | $13.95M | 0.14% | -$5.63M |
| Surrozen Inc | 0 | 393,560 | +393,560 | $0 | $12.66M | 0.13% | +$12.66M |
| Heartflow, Inc.(HTFL) | 295,000 | 250,000 | -45,000 | $8.66M | $12.44M | 0.13% | +$3.78M |
| Freenome Inc | 0 | 742,500 | +742,500 | $0 | $11.69M | 0.12% | +$11.69M |
| Latigo Biotherapeutics Inc | 0 | 700,000 | +700,000 | $0 | $11.69M | 0.12% | +$11.69M |
| Silence Therapeutics plcADS(SLN) | 0 | 700,000 | +700,000 | $0 | $7.65M | 0.08% | +$7.65M |
| Ocugen Inc | 6,666,666 | 6,666,666 | 0 | $10.20M | $6.87M | 0.07% | -$3.33M |
| Milestone Pharmaceuticals In | 7,833,336 | 7,833,336 | 0 | $10.50M | $6.78M | 0.07% | -$3.72M |
| Adarx Pharmaceuticals Inc | 0 | 300,000 | +300,000 | $0 | $5.98M | 0.06% | +$5.98M |
| Crescent Biopharma Inc. | 372,856 | 372,856 | 0 | $6.71M | $5.44M | 0.05% | -$1.27M |
| Allogene Therapeutics Inc | 3,250,000 | 3,250,000 | 0 | $6.76M | $5.20M | 0.05% | -$1.56M |
| Lumexa Imaging Holdings, Inc.(LMRI) | 650,000 | 500,000 | -150,000 | $7.33M | $5.13M | 0.05% | -$2.21M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 300,000 | +300,000 | $0 | $4.83M | 0.05% | +$4.83M |
| Regenxbio Inc | 0 | 555,555 | +555,555 | $0 | $4.18M | 0.04% | +$4.18M |
| Kalaris Therapeutics Inc | 1,300,000 | 1,300,000 | 0 | $5.29M | $3.76M | 0.04% | -$1.53M |
| ABIVAX Société AnonymeADS(ABVX) | 26,400 | 26,400 | 0 | $3.52M | $2.61M | 0.03% | -$903.9K |
| Medline Inc.CL A(MDLN) | 70,000 | 70,000 | 0 | $2.76M | $2.43M | 0.02% | -$331.8K |
| Capricor Therapeutics Inc | 250,000 | 250,000 | 0 | $6.02M | $2.37M | 0.02% | -$3.65M |
| Disc Medicine, Inc.(IRON) | 30,000 | 30,000 | 0 | $2.19M | $1.96M | 0.02% | -$230.4K |
| Evommune Inc | 1,502,235 | 208,071 | -1,294,164 | $19.96M | $1.72M | 0.02% | -$18.25M |
| Obsidian Therapeutics Inc | 0 | 67,706 | +67,706 | $0 | $929.6K | 0.01% | +$929.6K |
| Lexeo Therapeutics Inc | 0 | 239,149 | +239,149 | $0 | $808.3K | 0.01% | +$808.3K |
| 4d Molecular Therapeutics In | 475,737 | 0 | -475,737 | $6.33M | $0 | — | -$6.33M |
| Alkermes plcSHS(ALKS) | 1,672,356 | 0 | -1,672,356 | $87.62M | $0 | — | -$87.62M |
| Ataibeckley Inc | 2,000,000 | 0 | -2,000,000 | $10.54M | $0 | — | -$10.54M |
| Avalo Therapeutics, Inc.(AVTX) | 175,000 | 0 | -175,000 | $3.23M | $0 | — | -$3.23M |
| Definium Therapeutics, Inc.(DFTX) | 400,000 | 0 | -400,000 | $18.82M | $0 | — | -$18.82M |
| Exagen Inc.(XGN) | 195,000 | 0 | -195,000 | $906.8K | $0 | — | -$906.8K |
| IDEAYA Biosciences, Inc.(IDYA) | 370,370 | 0 | -370,370 | $13.80M | $0 | — | -$13.80M |
| ImageneBio, Inc.(IMA) | 334,445 | 0 | -334,445 | $1.97M | $0 | — | -$1.97M |
| Maze Therapeutics, Inc.(MAZE) | 212,000 | 0 | -212,000 | $6.33M | $0 | — | -$6.33M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 742,500 | 0 | -742,500 | $8.08M | $0 | — | -$8.08M |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 350,000 | 0 | -350,000 | $1.2K | $0 | — | -$1.2K |
| Tenax Therapeutics, Inc.(TENX) | 696,570 | 0 | -696,570 | $10.14M | $0 | — | -$10.14M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,350,000 | 0 | -1,350,000 | $7.84M | $0 | — | -$7.84M |